Milestone Pharmaceuticals Launches Public Offering To Support Etripamil Development
11/7 20:50
(RTTNews) - Milestone Pharmaceuticals Inc. (MIST) has initiated an underwritten public offering of its common shares, Series A and Series B warrants for purchasing common shares, and, for certain investors, pre-funded warrants in place of common shares....